Abstract
Objective:
Recently, a subtype of obesity characterized as a metabolically healthy but obese (MHO) individual has been identified. However, limited data are available on these MHO individuals’ metabolic and inflammatory profiles, and the effect of weight loss on these profiles. We investigated metabolic and inflammatory markers in MHO women to determine the effects of a 12-week weight loss on those markers.
Subjects:
One hundred and twenty-nine overweight-obese Korean women participated for 12 weeks in a clinical intervention study involving a 300 kcal/day intake reduction. The subjects were divided into two groups: MHO and metabolically abnormal obese (MAO) individuals.
Methods:
Computed tomography was performed. C-reactive protein (CRP), interkeukin-6 (IL-6) and oxidized low-density lipoprotein (LDL), as well as blood lipids, glucose and insulin concentrations were determined at baseline and after weight loss.
Results:
At baseline, plasma CRP (P<0.001), IL-6 (P<0.05) and oxidized LDL (P<0.001) levels were significantly lower in the MHO group than in the MAO group. Visceral fat at L1 (P<0.005) and visceral fat at L4 (P<0.001) were significantly lower in the MHO group than in the MAO group. The treatment induced weight loss averaging 3.11% of initial body weight, and the degree of weight loss between the two groups was similar. Visceral fat at L1 and L4 was reduced from its initial values by 3.2 and 5.4%, respectively, after weight loss. The levels of CRP (P<0.05) and oxidized LDL (P<0.01) were significantly reduced in the MAO group after the 12-week weight loss, whereas these effects were not seen in the MHO group.
Conclusions:
Our results showed that MHO individuals exhibited lower visceral fat accumulation and more favorable metabolic and inflammatory states than MAO individuals. After a 12-week weight loss program, significant reductions in blood lipids, CRP and oxidized LDL levels were observed in MAO individuals. However, there was no measurable effect of weight loss on lipid profiles and inflammation in MHO individuals, indicating differing effects of weight loss on these markers between MAO and MHO groups.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Must A, Spadano EH, Coakley EH, Field AE, Colditz G, Dietz WH . The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–1529.
National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160: 898–904.
Marchesini G, Melchionda N, Apolone G, Cuzzolaro M, Mannucci E, Corica F, et al., QUOVADIS Study Group. The metabolic syndrome in treatment-seeking obese persons. Metabolism 2004; 53: 435–440.
Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F . Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005; 13: 1116–1122.
Sims A . Are there persons who are obese, but metabolically healthy? Metabolism 2001; 50: 1499–1504.
Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EAH et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020–1025.
Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET . Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89: 2569–2575.
Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U . Insulin action and age. European group for the study of insulin resistance (EGIR). Diabetes 1996; 45: 947–953.
Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G . Insulin resistance and hypersecretion in obesity. European group for the study of insulin resistance (EGIR). J Clin Invest 1997; 100: 1166–1173.
Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Mario UD et al. Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 2002; 10: 767–773.
Iacobellis G . True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction. J Am Coll Cardiol 2004; 44: 2257.
Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prudhomme D et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145–4150.
National Cholesterol Education Program Expert Panel. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143–3421.
National Rural Living Science Institute. Food Composition Tables, 7th edn. National Rural Living Science Institute: Suwon, Korea, 2000 (in Korean).
Christian JL, Greger JH . Nutrition for Living. The Benjamin/Cummings Publishing Co Inc.: Menlo Park, CA, 1991; 111pp.
The American Dietetic Association. Handbook of Clinical Dietetics, 2nd edn. Yale University Press: New Haven, CT, 1992. pp 5–39.
Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Karelis AD . Clinical markers for the identification of metabolically healthy but obese individuals. Diabetes Obese Metab 2004; 6: 456–457.
Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F . Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 1999; 99: 2221–2222.
Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972–978.
Festa A, D’Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner S . Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 1000; 102: 42–47.
McLauhglin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002; 106: 2908–2912.
Bastard JP, Jardel C, Bruckert E, Vidal H, Hainque B . Variations in plasma soluble tumor necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obese Metab 2000; 2: 323–325.
Heilbronn LK, Noakes M, Clifton PM . Energy restriction and weight loss on very low fat diets reduces C-reactive protein concentrations in obese–healthy women. Arterioscler Thromb Vasc Biol 2001; 1: 968–970.
Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338–3342.
van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW . Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004; 89: 4062–4068.
Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2004; 89: 2697–2703.
Nicklas BJ, You T, Pahar M . Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Can Med Assoc J 2005; 26: 172–179.
Oflaz H, Ozbey N, Mantar F, Genchellac H, Mercanoglu F, Sencer E et al. Determination of endothelial function and early atherosclerosis changes in healthy obese women. Diabetes Nutr Metab 2003; 16: 176–181.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808.
Acknowledgements
We thank Ronald M Krauss of Children's Hospital Oakland Research Institute (CHORI) for his comments and suggestions. Financial support was provided by (1) National Research Laboratory project, Ministry of Science & Technology (2005-01572), (2) Korea Science and Engineering Foundation (R01-2003-0000-11709-0) and (3) Korea Health 21 R&D Projects, Ministry of Health & Welfare (00-PJ3-PG6-GN-01-0001), Republic of Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shin, MJ., Hyun, Y., Kim, O. et al. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes 30, 1529–1534 (2006). https://doi.org/10.1038/sj.ijo.0803304
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0803304
Keywords
This article is cited by
-
Relationships between obesity markers and bone parameters in community-dwelling older adults
Aging Clinical and Experimental Research (2024)
-
Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity
Molecular Biology Reports (2023)
-
Associations of obesity phenotypes with weight change, cardiometabolic benefits, and type 2 diabetes incidence during a lifestyle intervention: results from the PREVIEW study
International Journal of Obesity (2023)
-
Long-term impact of the metabolic status on weight loss-induced health benefits
Nutrition & Metabolism (2022)
-
Metabolically healthy obesity and metabolically obese normal weight: a review
Journal of Physiology and Biochemistry (2021)